Obstetrics and Gynaecology, OLVG, Amsterdam, The Netherlands
Obstetrics and Gynaecology, OLVG, Amsterdam, The Netherlands.
BMJ Case Rep. 2021 Jan 18;14(1):e237824. doi: 10.1136/bcr-2020-237824.
Lymphangioleiomyomatosis (LAM) is a progressive cystic lung disease which mostly affects premenopausal women and could be exacerbated by pregnancy. Therefore, it is thought that oestrogen plays an important role in LAM pathogenesis. Here, a case of LAM is described in which the first presentation of symptoms occurred during the third trimester of pregnancy. Symptoms included acute onset dyspnoea and chest pain at gestational age of 39 weeks and 2 days. A CT was performed which showed multiple thin-walled cysts and a small pneumothorax. Serum levels of vascular endothelial growth factor-D (VEGF-D) was 1200 pg/mL. The typical cystic lung changes on chest CT in combination with elevated VEGF-D is diagnostic for LAM. Given the risk of respiratory complications, the decision was made to deliver the baby at a gestational age of 39 weeks and 6 days by a planned caesarean section. Both mother and child were discharged home in good condition.
淋巴管平滑肌瘤病(LAM)是一种进行性囊性肺疾病,主要影响绝经前妇女,并可能因妊娠而加重。因此,雌激素被认为在 LAM 的发病机制中起重要作用。本文描述了一例 LAM 患者,其症状首次出现于妊娠晚期。症状包括在妊娠 39 周零 2 天时突然出现呼吸困难和胸痛。进行了 CT 检查,显示多个薄壁囊肿和小量气胸。血清血管内皮生长因子-D(VEGF-D)水平为 1200pg/mL。胸部 CT 上典型的囊性肺改变结合升高的 VEGF-D 可诊断为 LAM。鉴于呼吸并发症的风险,决定在妊娠 39 周零 6 天行计划性剖宫产分娩。母婴均状况良好出院。